VSQM
UTHR icon

V-Square Quantitative Management’s United Therapeutics UTHR Stock Holding History

V-Square Quantitative Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.4K Buy
141
+8
+6% +$4.5K 0.01% 551
2026
Q1 		$78.9K Buy
133
+16
+14% +$7.97K 0.01% 557
2025
Q4 		$57K Buy
+117
New +$54.5K 0.01% 570
2025
Q3 		– Sell
-113
Closed -$32.5K – 571
2025
Q2 		$32.5K Sell
113
-4
-3% -$1.2K ﹤0.01% 559
2025
Q1 		$36.1K Hold
117
– – 0.01% 609
2024
Q4 		$41.3K Buy
117
+4
+4% +$1.47K 0.01% 593
2024
Q3 		$40.5K Buy
113
+19
+20% +$6.42K 0.01% 564
2024
Q2 		$29.9K Buy
+94
New +$24.9K ﹤0.01% 562

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

V-Square Quantitative Management's UTHR Position: Q2 2026 in Review

V-Square Quantitative Management increased its United Therapeutics (UTHR) stake by 6% in Q2 2026, buying an estimated $4.5K and bringing the position to 141 shares worth $76.4K. The position accounts for 0.01% of the portfolio, ranked #551.

V-Square Quantitative Management first reported a position in UTHR in Q2 2024 and has held it in 8 quarters since. The position peaked at $78.9K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • V-Square Quantitative Management held 141 shares of United Therapeutics worth $76.4K as of Q2 2026.
  • V-Square Quantitative Management bought 8 United Therapeutics shares in Q2 2026, an estimated $4.5K.
  • United Therapeutics made up 0.01% of V-Square Quantitative Management's portfolio in Q2 2026, its #551 holding.
  • V-Square Quantitative Management first reported a position in United Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • V-Square Quantitative Management's United Therapeutics position peaked at $78.9K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.